Low kidney volume is linked with higher chronic kidney disease risk, independent of eGFR and albuminuria. Kidney volume may improve classification of chronic kidney disease (CKD) risk, investigators ...
Chronic Kidney Disease (CKD) signifies persistent kidney damage lasting over three months. The best indicator of kidney function is the Glomerular Filtration Rate (GFR), which measures how effectively ...
In the phase 2 MIRO-CKD trial, 12 weeks of balcinrenone combined with dapagliflozin reduced albuminuria compared with dapagliflozin alone added to standard of care in patients with stage 3-4 CKD.
Chronic kidney disease (CKD) is a progressive condition in which the kidneys are damaged and can’t filter blood effectively. This can eventually lead to a buildup of waste and fluid in the body. In ...
– Late-breaking presentation of Explore-CKD trial at ASN Kidney Week – – Pivotal Phase 3 Launch-HTN trial featured in the “Best of JAMA and NEJM” session - RADNOR, Pa., Nov. 07, 2025 (GLOBE NEWSWIRE) ...
A 16-µg dose of lubiprostone, a medication used in the management of constipation, improved or preserved estimated glomerular filtration rate (eGFR) in patients with chronic kidney disease (CKD), ...
Editor’s note: This is a previously posted video, and the below is an automatically generated transcript to be used for informational purposes. Please notify [email protected] if there are concerns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback